Literature DB >> 30447934

Canonical BMP signaling in tubular cells mediates recovery after acute kidney injury.

Emilia Vigolo1, Lajos Markó2, Christian Hinze3, Dominik N Müller4, Ruth Schmidt-Ullrich1, Kai M Schmidt-Ott5.   

Abstract

Bone morphogenetic protein (BMP) signaling has been shown to modulate the development of renal fibrosis in animal models of kidney injury, but the downstream mediators are incompletely understood. In wild-type mice, canonical BMP signaling mediated by SMAD1/5/8 transcription factors was constitutively active in healthy renal tubules, transiently down-regulated after ischemia reperfusion injury (IRI), and reactivated during successful tubular regeneration. We then induced IRI in mice with a tubular-specific BMP receptor 1A (BMPR1A) deletion. These mice failed to reactivate SMAD1/5/8 signaling in the post-ischemic phase and developed renal fibrosis after injury. Using unbiased genomic analyses, we identified three genes encoding inhibitor of DNA-binding (ID) proteins (Id1, Id2, and Id4) as key targets of BMPR1A-SMAD1/5/8 signaling. BMPR1A-deficient mice failed to re-induce these targets following IRI. Instead, BMPR1A-deficiency resulted in activation of pro-fibrotic signaling proteins that are normally repressed by ID proteins, namely, p38 mitogen-activated protein kinase and cell cycle inhibitor p27. These data indicate that the post-ischemic activation of canonical BMP signaling acts endogenously to repress pro-fibrotic signaling in tubular cells and may help to prevent the progression of acute kidney injury to chronic kidney disease.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SMAD transcription factors; fibrosis; ischemia reperfusion injury; renal tubular epithelial cells

Mesh:

Substances:

Year:  2018        PMID: 30447934     DOI: 10.1016/j.kint.2018.08.028

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

2.  Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.

Authors:  Richard Coffey; Grace Jung; Joseph D Olivera; Gabriel Karin; Renata C Pereira; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

3.  Mesenchymal Stem Cells-Derived Exosomes Ameliorate Ischemia/Reperfusion Induced Acute Kidney Injury in a Porcine Model.

Authors:  Jianni Huang; Hao Cao; Binbin Cui; Xiaoyan Ma; Ling Gao; Chao Yu; Fengchen Shen; Xinyu Yang; Na Liu; Andong Qiu; Guangyan Cai; Shougang Zhuang
Journal:  Front Cell Dev Biol       Date:  2022-05-24

4.  α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease.

Authors:  Lydia Hering; Masudur Rahman; Henning Hoch; Lajos Markó; Guang Yang; Annika Reil; Mina Yakoub; Vikram Gupta; Sebastian A Potthoff; Oliver Vonend; Donna L Ralph; Susan B Gurley; Alicia A McDonough; Lars C Rump; Johannes Stegbauer
Journal:  J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 10.121

5.  Kidney Single-cell Transcriptomes Predict Spatial Corticomedullary Gene Expression and Tissue Osmolality Gradients.

Authors:  Christian Hinze; Nikos Karaiskos; Anastasiya Boltengagen; Katharina Walentin; Klea Redo; Nina Himmerkus; Markus Bleich; S Steven Potter; Andrew S Potter; Kai-Uwe Eckardt; Christine Kocks; Nikolaus Rajewsky; Kai M Schmidt-Ott
Journal:  J Am Soc Nephrol       Date:  2020-11-25       Impact factor: 10.121

6.  Over-Expression of Inhibitor of Differentiation 2 Attenuates Post-Infarct Cardiac Fibrosis Through Inhibition of TGF-β1/Smad3/HIF-1α/IL-11 Signaling Pathway.

Authors:  Lin Yin; Ming-Xin Liu; Wei Li; Feng-Yuan Wang; Yan-Hong Tang; Cong-Xin Huang
Journal:  Front Pharmacol       Date:  2019-11-13       Impact factor: 5.810

7.  Human kidney clonal proliferation disclose lineage-restricted precursor characteristics.

Authors:  Osnat Cohen-Zontag; Rotem Gershon; Orit Harari-Steinberg; Tomer Kalisky; Benjamin Dekel; Naomi Pode-Shakked; Itamar Kanter; Dorit Omer; Oren Pleniceanu; Gal Tam; Sarit Oriel; Herzel Ben-Hur; Guy Katz; Zohar Dotan
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

8.  End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression.

Authors:  Ruijing Zhang; Jason Saredy; Ying Shao; Tian Yao; Lu Liu; Fatma Saaoud; William Y Yang; Yu Sun; Candice Johnson; Charles Drummer; Hangfei Fu; Yifan Lu; Keman Xu; Ming Liu; Jirong Wang; Elizabeth Cutler; Daohai Yu; Xiaohua Jiang; Yafeng Li; Rongshan Li; Lihua Wang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

Review 9.  Molecular Mechanisms of Kidney Injury and Repair in Arterial Hypertension.

Authors:  Laura Katharina Sievers; Kai-Uwe Eckardt
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

Review 10.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.